DAA Treatment Improves Liver Function, Increases Risk of Anemia in Patients With HCV, Study Finds
DAA Treatment Improves Liver Function, Increases Risk of Anemia in Patients With HCV, Study Finds
About this item
Full title
Author / Creator
Publisher
Cranbury: MultiMedia Healthcare Inc
Journal title
Language
English
Formats
Publication information
Publisher
Cranbury: MultiMedia Healthcare Inc
Subjects
More information
Scope and Contents
Contents
The liver function of patients with hepatitis C virus (HCV) improved while prevalence of anemia increased and fasting blood glucose level, hemoglobin A1C index, and renal function decreased after 12 weeks of treatment with direct-acting antivirals (DAA), according to findings from a recent study. In their 2022 guidelines, the WHO recommended DAA th...
Alternative Titles
Full title
DAA Treatment Improves Liver Function, Increases Risk of Anemia in Patients With HCV, Study Finds
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_reports_2863701974
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_reports_2863701974
Other Identifiers
ISSN
2767-7168
E-ISSN
2767-7168
